| Bromhexine Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup |
|
| Levofloxacin Oral Solution (vet) |
|
| Norfloxacin Oral Powder (vet) |
|
| Esomeprazole Fast Releasing Tablets |
|
| Ambroxol Hydrochloride Drops |
|
| Amlodipine & Hydrochlorothiazide Tablets |
|
| Florfenicol Oral Solution (Vet) |
|
| Levetiracetam Dispersible Tablets |
|
| Cefdinir Tablets |
|
| Flunarizine Tablets |
|
| Ivabradine Tablets |
|
| Ticagrelor tablets |
|
| Cefpodoxime Proxetil and Potassium Clavulanate Dispersible Tablets |
|
| Cefpodoxime Proxetil and Potassium Clavulanate Dispersible Tablets |
|
| Cefpodoxime Proxetil and Potassium Clavulanate Tablets |
|
| Ambroxol Hydrochloride Syrup |
|
| Esomeprazole Sodium Powder for Injection |
|
| Progesterone Sustained Release Tablets |
|
| Metronidazole and Diloxanide Furoate Suspension |
|
| Moxifloxacin Eye Ointment |
|
| Enrofloxacin Oral Solution (Vet) |
|
| Linezolid and Dextrose IV Injection |
|
| Sodium Picosulfate Tablets |
|
| Salbutamol Sulphate and Bromhexine HCl Syrup |
|
| Amlodipine & Ramipril Tablets |
|
| Iron Polymaltose and Folic acid Capsules |
|
| Sucralfate Suspension |
|
| Teneligliptin Tablets |
|
| Granisetron Syrup |
|
| Granisetron Mouth Dissolving Tablets |
|
| Tapentadol Tablets |
|
| Potassium Iodide, Sodium Chloride & Calcium Chloride Ophthalmic solution |
|
| Ibandronate Sodium Tablets |
|
| Telmisartan and Chlorthalidone Tablets |
|
| Bromhexine Hydrochloride & Terbutaline Sulphate Syrup |
|
| Nimesulide Tablets |
|
| Calcium Polystyrene Sulphonate Oral Powder |
|
| Dextromethorphan HBr, Triprolidine HCl & Phenylephrine HCl Tablets |
|
| Cefpodoxime Dispersible Tablets |
|
| Sevelamer Carbonate Tablets |
|
| Ornidazole Tablets |
|
| Deflazacort Tablets |
|
| Empagliflozin Tablets |
|
| Cefoperazone & Sulbactam for injection |
|
| Sofosbuvir & Ledipasvir Tablet |
|
| Clobazam Mouth Dissolving Tablet |
|
| Daclatasvir Tablets |
|
| S (-) Pantoprazole Enteric Coated Tablets |
|
| Tropicamide and Phenylephrine HCl Ophthalmic Solution |
|
| Dabigatran Etexilate Capsules |
|
| Dutasteride Tablets |
|
| Disodium Hydrogen Citrate Syrup |
|
| Cefpodoxime and Potassium Clavulanate Powder for Oral Suspension |
|
| Itopride HCL Sustained Release Tablets |
|
| Aceclofenac Sustained Release Tablet |
|
| Sodium Valproate and Valproic Acid Sustained ReleaseTablets |
|
| Metformin (Immediate Release) & Linagliptin Tablets |
|
| Metformin (Sustained Release) & Linagliptin Tablets |
|
| Rifaximin tablets |
|
| Paracetamol and Chlorzoxazone Tablets |
|
| Itopride HCl Tablet |
|
| Pantoprazole Powder for Injection |
|
| Metformin (Immediate Release) & Sitagliptin Tablets |
|
| Tapentadol Capsules |
|
| Ibuprofen & Paracetamol Tablets |
|
| Febuxostat Tablets |
|
| Metformin Sustained Release & Sitagliptin Tablets |
|
| Metformin Hydrochloride Prolonged-release and Glimepiride Tablets |
|
| Favipiravir Tablets |
|
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylephrine Hydrochloride Syrup |
|
| Amiloride and Frusemide Tablets |
|
| Metronidazole & Diloxanide Furoate tablet |
|
| Linagliptin Tablets |
|
| Paracetamol and Ibuprofen Suspension |
|
| Sofosbuvir Tablets |
|
| Fexofenadine Hydrochloride Suspension |
|
| Levocetirizine Dihydrochloride Syrup |
|
| Cefdinir Dispersible Tablets |
|
| Amlodipine and Atorvastatin Tablets |
|
| Esomeprazole Capsules |
|
| Desloratidine Tablets |
|
| Rabeprazole Capsules |
|
| Diacerin Tablets |
|
| Amlodipine and Telmisartan Tablets |
|
| List of molecules submitted for AMV from 2076-04-01 to 2077-06-21 |
|
| List of molecules under study in AMVC 2077-06-21 |
|
| Guideline on Analytical Method Validation on Non-pharmacopoeial Products for Regulatory Approval |
|
| Nepalese National Formulary 3rd Edition 2018 |
|
| Rivaroxaban Tablets |
|
| Metformin (Immediate Release) & Glimepiride Tablets |
|
| Folic acid & ferrous ascorbate tablets |
|
| Customer Satisfaction Form |
|
| Service Charge |
|
| Silodosin Capsules |
|
| Illaprazole Enteric Coated Tablets |
|
| National list of essential medicines Nepal (fifth revision) 2016 |
|
| Nepalese National Formulary 2nd Edition |
|
| Special permission guidance 2074 |
|
| National Guideline for Good Practices For Pharmaceutical Microbiology Laboratories, 2075 |
|
| National Guidelines for Good Practices For Pharmaceutical Quality Control Laboratories, 2075 |
|
| Health Technology Directives |
|
| Hospital_Pharmacy_Guideline_2072 |
|
| Medicine Registration Guidance |
|
| Public Procurement Rules 2064 |
|
| Public Procurement Act 2063 |
|
| National Drug Policy -1995 |
|
| GMP Codes 2072 |
|
| Nepal Health Service Rules, 2055 (1999) |
|
| Nepal Health Service Act, 2053 (1997) |
|
| Narcotic Drugs (Control) Act, 2033 (1976) |
|
| Codes-on-sales-and-Distribution-of-Drugs |
|
| The Consumer Protection Act, 2075 (2018) |
|
| National Health Policy 2076 |
|
| Drug Category Rules 2043 (1986) |
|
| Drug investigation and inspection rules 2040 (1983) |
|
| Drug Registration Regulation 2038 (1981) |
|
| DCC and DAC formation rules |
|
| Drug Act 2035 |
|
Downloads Page